Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by HitHardTrader35


T.VRX

VRX CEO Mike Pearson Sends Holiday Wishes from Hospital Bed

Valeant Pharmaceuticals (VRX) CEO, Mike Pearson, shows signs of improvement...

December 27, 2015

T.VRX

Good News: Guggenheim Reiterates Buy Rating with 70% Upside

Guggenheim reiterates BUY rating for Valeant Pharmaceuticals (NYSE) with a...

December 17, 2015

T.VRX

Valeant Shares Hit 20% High on Intraday (Dec 15)

Valeant Strongly Bullish, Hits 20% Intraday High   As a consequence...

December 15, 2015

T.VRX

$VRX Valeant Pharmaceuticals Files for Bankruptcy

Dear traders and investors, we had another good day with $VRX gaining +0.87...

December 14, 2015

T.VRX

Valeant's Frustrated Shareholders Pressure for Answers

You would think that a stock-price collapse of more than 60 percent might...

December 14, 2015

T.VRX

Valeant hires attorney, Crisis management firm

SARAH N. LYNCH AND DAVID INGRAM WASHINGTON/NEW YORK — Reuters ...

December 14, 2015

T.VRX

Traditional Stock Rally Dec 15. - Jan. 6.

The good news for Canadian investors is that, historically, Santa has been...

December 11, 2015

T.VRX

Valeant investors pressure Pearson for a new plan

By By Caroline Humer, Carl O'Donnell and Svea Herbst-Bayliss –

December 11, 2015

T.VRX

VALEANT PHARMACEUTICALS TURNS BULLISH: STRONG BUY RATING

Now 90% of all major analysts recommend "BUY" rating for VALEANT...

November 30, 2015

T.VRX

Short-Sellers Who Attacked Valeant are Real Fraudsters

Michelle Celarier from the New York Post put out a great article on Andrew...

November 30, 2015

T.VRX

More Support for VRX from Institutional Traders

It appears that support for Valeant Pharmaceuticals is gaining its momentum...

November 29, 2015

T.VRX

Malhotra: VRX Price Target $220 (Analyst = 85% Success Rate)

Shibani Malhotra from Nomura Holding met Valeant Pharmaceutical's CEO, J....

November 29, 2015

T.VRX

VRX Getting Stronger, Short-Sellers Weaker

Short-sellers are losing ground. VRX is bullish. So what do short...

November 28, 2015

T.VRX

RE:Valeant is a Fraud Victim, Not a Fraudster (Seeking Alpha)

Well said, quote from Seeking Alpha article: "While the Valeant (NYSE...

November 27, 2015

T.VRX

RE:RE:VRX: Sellers Losing Ground, Supply/Demand Evenly Balanced

Not only MACD & Linear Regression are pointing up, but Fast Stochastics...

November 26, 2015

T.VRX

RE:VRX Technical Analysis for Nov 26 and forward [ BULLISH ]

We're close. Linear Regression (Slope) now stands at -0.44 and should...

November 26, 2015

T.VRX

RE:RE:VRX Fundamentals are EXCELLENT, 128% Price Target

I agree. Between Nov 25th and middle of December, VRX should gain 20-30...

November 26, 2015

T.VRX

RE:VRX Technical Analysis for Nov 26 and forward [ BULLISH ]

Linear Regression is highly reliable. Many HFT (High Frequency Trading...

November 26, 2015

T.VRX

Is "Bronte Capital" Fraud or Not?

Today, some obscure company called "Bronte Capital" made misleading...

November 25, 2015

T.VRX

Valeant Publishes Rebuttals to Short-Sellers Lies

Short-sellers are losing ground with VRX. The stock was up more than 3...

November 25, 2015

1 2 3 Next

Featured Company